Voloridge Investment Management, LLC Morphic Holding, Inc. Transaction History

Voloridge Investment Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$26.12 - $34.07 $4.2 Million - $5.48 Million	160,896 New	160,896 $5.48 Million
Q4 2023 Feb 14, 2024	BUY	$19.95 - $31.0 $975,634 - $1.52 Million	48,904 Added 44.73%	158,240 $4.57 Million
Q3 2023 Nov 14, 2023	BUY	$21.33 - $59.42 $956,693 - $2.67 Million	44,852 Added 69.56%	109,336 $2.5 Million
Q2 2023 Aug 14, 2023	SELL	$34.33 - $62.11 $1.98 Million - $3.58 Million	-57,637 Reduced 47.2%	64,484 $3.7 Million
Q1 2023 May 15, 2023	BUY	$26.01 - $48.69 $373,139 - $698,506	14,346 Added 13.31%	122,121 $4.6 Million
Q4 2022 Feb 14, 2023	SELL	$24.14 - $30.37 $146,843 - $184,740	-6,083 Reduced 5.34%	107,775 $2.88 Million
Q3 2022 Nov 14, 2022	SELL	$22.23 - $33.37 $1.41 Million - $2.12 Million	-63,588 Reduced 35.84%	113,858 $3.22 Million
Q2 2022 Aug 15, 2022	BUY	$19.74 - $43.01 $3.5 Million - $7.63 Million	177,446 New	177,446 $3.85 Million

4.96M

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.